Inogen (INGN) Operating Expenses (2013 - 2026)

Inogen (INGN) has 14 years of Operating Expenses data on file, last reported at $47.2 million in Q1 2026.

• Quarterly Operating Expenses rose 7.2% year-over-year to $47.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $187.6 million (down 1.57% YoY) and the FY2025 annual result came in at $184.5 million, down 6.48% from the prior year.
• Operating Expenses advanced to $47.2 million in Q1 2026 per INGN's latest filing, from $44.5 million in the prior quarter.
• Across five years, Operating Expenses topped out at $88.0 million in Q4 2022 and bottomed at $44.0 million in Q1 2025.
• The 5-year median for Operating Expenses is $49.1 million (2022), against an average of $53.2 million.
• The widest annual swing landed in 2022, when Operating Expenses jumped 94.34%; it then slumped 38.95% in 2024.
• Tracing INGN's Operating Expenses over 5 years: stood at $88.0 million in 2022, then plunged by 35.04% to $57.1 million in 2023, then declined by 16.56% to $47.7 million in 2024, then decreased by 6.57% to $44.5 million in 2025, then climbed by 5.97% to $47.2 million in 2026.
• Per Business Quant, the three latest INGN Operating Expenses figures stand at $47.2 million (Q1 2026), $44.5 million (Q4 2025), and $48.4 million (Q3 2025).

Peer Comparison